PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24295151 ↗2014Reported benefit

The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.

MouseEndotoxin/LPSintraperitoneal25 mg/kg12 h after intratracheal LPS, before hyperoxia exposure

Model: Acute respiratory distress syndrome induced by a single intratracheal dose of lipopolysaccharide (0.375 microg/g) followed by exposure to hyperoxia (>95% O2)

Aurothioglucose significantly attenuated LPS plus hyperoxia induced lung injury, increased lung GCLM expression and glutathione levels, and decreased mortality. Glutathione depletion completely prevented the protective effects, indicating the benefit is glutathione dependent.

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.